|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2005-6-21
|
|
pubmed:abstractText |
Levocetirizine is an antihistamine with high affinity and selectivity for H1-receptors, which exhibits an excellent benefit/risk ratio in the treatment of allergic rhinitis and urticaria. This is the first study performed with this drug in very young children.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0946-1965
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
172-7
|
|
pubmed:meshHeading |
pubmed-meshheading:15966463-Age Factors,
pubmed-meshheading:15966463-Cetirizine,
pubmed-meshheading:15966463-Cough,
pubmed-meshheading:15966463-Female,
pubmed-meshheading:15966463-Histamine H1 Antagonists, Non-Sedating,
pubmed-meshheading:15966463-Humans,
pubmed-meshheading:15966463-Infant,
pubmed-meshheading:15966463-Male,
pubmed-meshheading:15966463-Piperazines,
pubmed-meshheading:15966463-Recurrence,
pubmed-meshheading:15966463-Respiratory Hypersensitivity,
pubmed-meshheading:15966463-Respiratory Sounds,
pubmed-meshheading:15966463-Urticaria
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Levocetirizine in 1-2 year old children: pharmacokinetic and pharmacodynamic profile.
|
|
pubmed:affiliation |
Royal Children's Hospital and Murdoch Children's Research Institute, University of Melbourne, Australia.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
